<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F113D73A-143F-41B6-9680-98AF837D51DF"><gtr:id>F113D73A-143F-41B6-9680-98AF837D51DF</gtr:id><gtr:name>University of Antwerp</gtr:name><gtr:address><gtr:line1>Universiteitsplein 1</gtr:line1><gtr:line4>Antwerp</gtr:line4><gtr:line5>B-2610</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2"><gtr:id>F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2</gtr:id><gtr:name>University of Miami</gtr:name><gtr:address><gtr:line1>1204 Dickinson Drive</gtr:line1><gtr:line2>Rhodes House</gtr:line2><gtr:line3>Building 37-A</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Neuroscience</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F113D73A-143F-41B6-9680-98AF837D51DF"><gtr:id>F113D73A-143F-41B6-9680-98AF837D51DF</gtr:id><gtr:name>University of Antwerp</gtr:name><gtr:address><gtr:line1>Universiteitsplein 1</gtr:line1><gtr:line4>Antwerp</gtr:line4><gtr:line5>B-2610</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2"><gtr:id>F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2</gtr:id><gtr:name>University of Miami</gtr:name><gtr:address><gtr:line1>1204 Dickinson Drive</gtr:line1><gtr:line2>Rhodes House</gtr:line2><gtr:line3>Building 37-A</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CE3C67A1-C2FC-4AE1-8F5F-F356F1B8FF88"><gtr:id>CE3C67A1-C2FC-4AE1-8F5F-F356F1B8FF88</gtr:id><gtr:firstName>Rita</gtr:firstName><gtr:surname>Horvath</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000848"><gtr:id>DF2C1A5A-B7E6-4D1F-89E6-5BA9D2EE93B5</gtr:id><gtr:title>Molecular mechanism of the recovery in infantile reversible cytochrome c oxidase (COX) deficiency myopathy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000848</gtr:grantReference><gtr:abstractText>Childhood-onset mitochondrial diseases are usually severe, progressive conditions with fatal outcome. However, ?benign? (better, ?reversible?) cytochrome c oxidase deficiency myopathy is an exception because it shows spontaneous complete recovery if infants survive a critical postnatal period of severe weakness and respiratory failure. Although potentially benign, this myopathy is life-threatening in the first months of life and patients require vigorous life-sustaining measures. We have recently found that reversible COX deficiency myopathy is caused by a homoplasmic mt-tRNAGlu mutation m.14674T C. Neither the exact mechanism nor the molecular basis of the recovery is currently understood. Interestingly, some homoplasmic mutation carriers (siblings of patients) do not develop any signs of myopathy, strongly suggesting the existence of protective disease modifiers. Understanding the spontaneous improvement in this mitochondrial condition may reveal a more general insight in the disease pathomechanism, and similar compensatory factors may offer clues towards molecular therapies of at least some mitochondrial diseases. The long-term goal of this approach would be to upregulate or boost compensatory factors in patients with mitochondrial disease and exploit them for therapy.</gtr:abstractText><gtr:technicalSummary>We have recently identified the molecular genetic cause of a puzzling clinical syndrome, initially termed ?benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase (COX) deficiency?. While childhood-onset mitochondrial encephalomyopathies are usually severe, relentlessly progressive conditions with fatal outcome, this syndrome stands out by showing complete (or almost complete) spontaneous recovery. We have detected the homoplasmic m.14674T C mutation in the mitochondrial mt-tRNAGlu gene in 17 affected individuals from 12 independent families of different ethnic origins. The m.14674T C mutation affects the discriminator base of mt-tRNAGlu, the last base at the 3?-end of the molecule, where the amino acid via the terminal CCA is attached, therefore thought to impair mitochondrial translation, as reflected by the COX-negative fibres and the multiple respiratory chain defects in skeletal muscle. The identification of a homoplasmic mt-tRNA mutation in reversible COX deficiency myopathy raised a number of important issues. 
We will investigate, i) why patients with homoplasmic m.14674T C show an isolated muscle involvement, ii) why symptoms start uniformly in the first days or weeks of life, and iii) what is behind the molecular basis of the age-dependent, spontaneous recovery. The spontaneous recovery of the patients suggests the existence of so far unknown cellular compensatory mechanisms. We will study mt-tRNA processing and function in human primary cells and muscle of patients with reversible COX deficiency myopathy, and based on the results we will extend the investigations on different types of mitochondrial disease. 
The identification of the pathomechanism of reversible COX deficiency myopathy may have implications in other mitochondrial conditions. The long-term goal of this approach would be to upregulate or boost compensatory factors in patients with different types of mitochondrial disease with the aim to open new avenues for therap</gtr:technicalSummary><gtr:fund><gtr:end>2014-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>397290</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Miami</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Identifying novel disease genes in hereditary motor neuropathies</gtr:description><gtr:id>6515EB5D-F67E-4A08-86B1-98ADB4E0A4A0</gtr:id><gtr:impact>We have published a paper together in AJHG.</gtr:impact><gtr:outcomeId>5458f92ea92822.92671779-1</gtr:outcomeId><gtr:partnerContribution>The collaborators also had one family with another mutation in the same gene.</gtr:partnerContribution><gtr:piContribution>We have identified mutations in a novel disease gene in a family with autosomal dominant hereditary motor neuropathy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hebrew University of Jerusalem</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>Hebrew University Hadassah Medical School</gtr:department><gtr:description>Studying the function of the exosome in human disease.</gtr:description><gtr:id>5B2208C9-F3CE-4415-B4FF-F019B3E8AB8F</gtr:id><gtr:impact>We published a nice paper together (Boczonadi et al. 2014)</gtr:impact><gtr:outcomeId>5458f9ad16d557.31486706-1</gtr:outcomeId><gtr:partnerContribution>The partner had another family with mutations in the same gene.</gtr:partnerContribution><gtr:piContribution>We have identified a novel disease gene and performed functional studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Antwerp</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Metablic testing of serum and lymphoblastoid cells of patients with motor neuropathy</gtr:description><gtr:id>9365CC36-417D-4EC2-8841-8BC4564A35EB</gtr:id><gtr:impact>samples are currently being analysed</gtr:impact><gtr:outcomeId>58a1a83e4f7773.16019894-1</gtr:outcomeId><gtr:partnerContribution>Prof. Timmermann`s group convert the blood cells to lymphoblastoid cells.</gtr:partnerContribution><gtr:piContribution>We collected serum and blood samples of patients with hereditary motor neuropathies and Prof. Vincent Timmermann`s group converted them to lymphoblastoid cells and conduct metabolomics studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McGill University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Molecular Neurogenetics</gtr:department><gtr:description>Studying 2-thiolation of mt-tRNA Glu, Lys, Gln</gtr:description><gtr:id>F3F39DD3-5C85-4AD8-8BEC-0144D260FC41</gtr:id><gtr:impact>There is a Hom Mol Genet paper (Sasarman et al. 2011) already out of this collaboration.</gtr:impact><gtr:outcomeId>s6gNuUY8jZ8-1</gtr:outcomeId><gtr:partnerContribution>common publication</gtr:partnerContribution><gtr:piContribution>I have started to collaborate on the function of TRMU</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mitochondrial Biology Unit</gtr:department><gtr:description>Studying a novel mitochondrial carriers in a patient mitochondrial disease</gtr:description><gtr:id>02F5B233-6162-4F52-962E-E1B7B6F4FDFE</gtr:id><gtr:impact>We are currently drafting a manuscript.</gtr:impact><gtr:outcomeId>5458f89dec44a3.07631747-1</gtr:outcomeId><gtr:partnerContribution>Dr. Edmund Kunji`s laboratory performed functional analysis of the carrier to prove that the mutation is pathogenic.</gtr:partnerContribution><gtr:piContribution>We identified a patient with mutations in a novel mitochondrial carrier protein.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Neurological Institute of New York</gtr:department><gtr:description>Search for modifyers in reversible COX deficiency</gtr:description><gtr:id>2698DC7C-B86A-4FDE-90AD-87537E5CDE20</gtr:id><gtr:impact>currently being worked up</gtr:impact><gtr:outcomeId>Xmn4coNwHE9-1</gtr:outcomeId><gtr:partnerContribution>contributing further families</gtr:partnerContribution><gtr:piContribution>I contribute a large family and performed exome sequencing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Ataxia UK Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>94E87AF6-AABE-4A9C-B0A5-04290A902F6A</gtr:id><gtr:impact>About 60 patients and their families attended this meeting.

Patients appreciated my answers on their questions.</gtr:impact><gtr:outcomeId>5458fa90d54425.44059305</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Session at UMDF meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F5979E35-9F35-4B1E-9555-51501A752954</gtr:id><gtr:impact>I was participating in the patient session and answered the questions of patients at the United Mitochondriaql Disease Foundation Meeting (Newport Beach, USA)

I hope tha patients profited from my answers</gtr:impact><gtr:outcomeId>GCs1YVHghHh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Euromit Meeting, Tampere, Patient Session</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>658FE4B4-0AE5-47F0-B85F-880518F2B6DE</gtr:id><gtr:impact>I gave presentations for the patients.

Patients learned about their condition and about potential treatments, diagnostics methods.</gtr:impact><gtr:outcomeId>5458fb0b229c55.10210969</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SSIEM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32341049-AA51-4EC4-A099-04C884845463</gtr:id><gtr:impact>1500 congress participiants were listening my presentation on Coenzyem Q10 deficiencies

referral of patients with CoQ10 defect</gtr:impact><gtr:outcomeId>Pnxuu8pro9n</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FP7 ERC Starter Grants</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>309548</gtr:fundingRef><gtr:id>068988CC-AFAE-483A-BE12-71D56AE8F6C9</gtr:id><gtr:outcomeId>auwPJWXNB4N</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>We are testing the feasibility of bezafibrate supplementation in MELAS. Trial is currently ongoing.</gtr:description><gtr:id>197F2B90-8DC3-4E85-B640-4C20C19503DB</gtr:id><gtr:impact>trial is ongoing</gtr:impact><gtr:outcomeId>56c9ebe3dfa075.38570180</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>A Study of Bezafibrate in Mitochondrial Myopathy&quot; (NUTH NHS Trust, 2015)</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We can successfully convert human finroblasts into induced neuronal progenitor cells.</gtr:description><gtr:id>99B42144-FE0F-4E7A-91F8-FAADC2E72480</gtr:id><gtr:impact>We have already converted 4 patient and 2 contol cell lines into induced neuronal progenitor cells. Currently the analysis of mitochondrial function is in progress in these cells.</gtr:impact><gtr:outcomeId>56c9ea85acbf71.29796014</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>induced neuronal progenitor cells</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I used zebrafish to model human disease.</gtr:description><gtr:id>45F4C0C2-C2C2-491D-87E0-3461EA517F63</gtr:id><gtr:impact>Published a paper (Boczonadi et al. 2014)</gtr:impact><gtr:outcomeId>5458fbbf764502.16289811</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>zebrafish</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Measuring the oxidative capacity of patient cell lines.</gtr:description><gtr:id>625FCDA6-829C-4EA2-A5B0-B7D6D7018C4D</gtr:id><gtr:impact>We used this method in several projects and publications.</gtr:impact><gtr:outcomeId>5458fb7564ac08.01608100</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Seahorse analysis</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>we have obtained cells (fibrobalsts and myoblasts) from a patient and established a special technique to study 2-thiolation of mt-tRNAs</gtr:description><gtr:id>31F7E3AC-128C-490F-ACCA-1FC786E6BD90</gtr:id><gtr:impact>We are currently investigating the possible role of 2-thiolation as a possible disease mechanism in reversible COX deficiency as part of the project</gtr:impact><gtr:outcomeId>JuqhS4ofyBT</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TRMU cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>functional analysis of human patient cell lines</gtr:description><gtr:id>FB314925-3C26-40F3-90A1-BD1CC16D325E</gtr:id><gtr:impact>we revealed the pathomechanism of mitochondrial disease in 20 patients</gtr:impact><gtr:outcomeId>VP2CJwBBaui</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BN-PAGE</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CF801BCB-661F-4DD0-A3E7-F6D467F0A2A1</gtr:id><gtr:title>Investigating the role of the physiological isoform switch of cytochrome c oxidase subunits in reversible mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5675df9115244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>236A8048-8EA3-4035-936A-BB31BD07AED5</gtr:id><gtr:title>Novelmutation causes both motor neuronopathy and distal myopathy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25be39d66aab491cf7b7f931f987c64c"><gtr:id>25be39d66aab491cf7b7f931f987c64c</gtr:id><gtr:otherNames>Lewis-Smith DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58a19f80f183e3.24978617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C58C8BA7-C405-45EF-96FE-CBB6696EBD24</gtr:id><gtr:title>Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56c9e47fe6d6a2.25947337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CDF9C29-C634-47A9-8C2F-AB330DC8C28C</gtr:id><gtr:title>Mitochondrial DNA deletions in muscle satellite cells: implications for therapies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47b704140988a2c45c6d81ab167821ff"><gtr:id>47b704140988a2c45c6d81ab167821ff</gtr:id><gtr:otherNames>Spendiff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12524_24_23847047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FBF50E-62E6-4F52-A11D-04D6853B78C4</gtr:id><gtr:title>Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d5d618d31b1d170b90a2083007ae6c"><gtr:id>45d5d618d31b1d170b90a2083007ae6c</gtr:id><gtr:otherNames>Payne BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>L6qgzLtmazk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1480174B-F4A7-4A63-8D01-2C5E3935F4A7</gtr:id><gtr:title>The swinging pendulum of biomarkers in mitochondrial disease: The role of FGF21.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a619845b5cc71248eec5a3b2a35994cb"><gtr:id>a619845b5cc71248eec5a3b2a35994cb</gtr:id><gtr:otherNames>Steele HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58a19f80c41505.97714210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A159FFA-9C9A-4E9B-AFA0-ADAF4107FBED</gtr:id><gtr:title>Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9533a2187fefc0bd551084d2f37d352"><gtr:id>c9533a2187fefc0bd551084d2f37d352</gtr:id><gtr:otherNames>Garcia-Diaz B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_12524_24_23022099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9A22793-4663-46A3-9AB1-64B38243C610</gtr:id><gtr:title>Nuclear-mitochondrial proteins: too much to process?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5675e53bc3cec</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15903186-849C-4866-9CF8-123BCCAFA93B</gtr:id><gtr:title>Late-onset sacsinopathy diagnosed by exome sequencing and comparative genomic hybridization.</gtr:title><gtr:parentPublicationTitle>Journal of neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-7063</gtr:issn><gtr:outcomeId>5458f61929f585.24636620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89BCC0B9-6EE8-4456-ADEF-A6806CA3F3C1</gtr:id><gtr:title>Pathogenic mtDNA mutations causing mitochondrial myopathy: The need for muscle biopsy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b7263415ae4e7309f53b879324200c"><gtr:id>61b7263415ae4e7309f53b879324200c</gtr:id><gtr:otherNames>Hardy SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58a19f802fc0d8.54833910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3C7EB2-A955-4E50-A94D-504A3A0CCE64</gtr:id><gtr:title>Novel genetic and neuropathological insights in neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP).</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9987d640645c09cb36affb6e72ff04"><gtr:id>9c9987d640645c09cb36affb6e72ff04</gtr:id><gtr:otherNames>Claeys KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>585d6959c5fac0.02336824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC95EC5D-6EA2-4F97-8D02-2AD4EB93C306</gtr:id><gtr:title>The p.Ser107Leu in BICD2 is a mutation 'hot spot' causing distal spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40a020e11c4ea5657e5f2e6f3485cfd0"><gtr:id>40a020e11c4ea5657e5f2e6f3485cfd0</gtr:id><gtr:otherNames>Bansagi B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56c9e47fb670d0.93219336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1D659C7-8728-4457-AAC5-4477248F12CC</gtr:id><gtr:title>Respiratory-chain deficiency presenting as diffuse mesangial sclerosis with NPHS3 mutation.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be8aad78d907216641ef143ad4baffe3"><gtr:id>be8aad78d907216641ef143ad4baffe3</gtr:id><gtr:otherNames>Baskin E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>gGK8DJYV2Jb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F446D4F5-0943-4317-949F-EE0E71F665F6</gtr:id><gtr:title>The 2-thiouridylase function of the human MTU1 (TRMU) enzyme is dispensable for mitochondrial translation.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ff02a93f3d510064f49c7df15791d26"><gtr:id>2ff02a93f3d510064f49c7df15791d26</gtr:id><gtr:otherNames>Sasarman F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>ho5V9TA7fXD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F5F0CA2-273A-4F78-91E5-CBAA2EAF086D</gtr:id><gtr:title>Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ba297a1edd6970078cb545704ad890"><gtr:id>79ba297a1edd6970078cb545704ad890</gtr:id><gtr:otherNames>Foley AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5458f5d11099b3.53055828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C12E130-7979-46B6-8D32-5401EF4472C5</gtr:id><gtr:title>Chronic and slowly progressive weakness of the legs and hands.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856a4d55b01d92abca12d16202621560"><gtr:id>856a4d55b01d92abca12d16202621560</gtr:id><gtr:otherNames>Nightingale H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5458f43fc09db2.01843494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D67182E7-13A3-458B-949E-A402173CCEA4</gtr:id><gtr:title>Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>VLrh4cg4MQD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19BFB8A9-5EF6-4F76-82B2-25152E3A64E7</gtr:id><gtr:title>A Mutation in the Flavin Adenine Dinucleotide-Dependent Oxidoreductase FOXRED1 Results in Cell-Type-Specific Assembly Defects in Oxidative Phosphorylation Complexes I and II.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eed66897b6b96d6a6bb33e5a37030a2"><gtr:id>0eed66897b6b96d6a6bb33e5a37030a2</gtr:id><gtr:otherNames>Zurita Rend?n O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>58a19f7fd0d008.99319101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55BCDD82-5D64-4330-9294-BD03FED8C51C</gtr:id><gtr:title>Toward a mtDNA locus-specific mutation database using the LOVD platform.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19cd9eac194029b31fc778c6567229da"><gtr:id>19cd9eac194029b31fc778c6567229da</gtr:id><gtr:otherNames>Elson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_55f94594528a451e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7712F428-1B45-4E24-BAEF-E7C53D365644</gtr:id><gtr:title>Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e87940e6460d8a108148a5e207bd528"><gtr:id>0e87940e6460d8a108148a5e207bd528</gtr:id><gtr:otherNames>Whittaker RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56c9e481750f54.81154286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA895D6A-A8F8-448F-B6A6-695652558628</gtr:id><gtr:title>Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5458f3d3450478.13493301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2467EB85-778B-45EC-A59C-A48DA9068F2A</gtr:id><gtr:title>Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>5458f3f6d354d0.68827578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>308F7735-8F17-46B9-96D4-BE96B2E47AFF</gtr:id><gtr:title>Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40a020e11c4ea5657e5f2e6f3485cfd0"><gtr:id>40a020e11c4ea5657e5f2e6f3485cfd0</gtr:id><gtr:otherNames>Bansagi B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5675e59a29992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD87FAFF-A39D-4280-8A61-8BFBBD340421</gtr:id><gtr:title>Charcot-Marie-Tooth disease in Northern England.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5d8387352f40d64df3d0eaefc8811bd"><gtr:id>d5d8387352f40d64df3d0eaefc8811bd</gtr:id><gtr:otherNames>Foley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>oSwaTSJNTAk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB126F03-77EC-42FC-8678-03EE5D43BB09</gtr:id><gtr:title>A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_12524_24_22508347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A570B2B-A1B7-4D96-9FBF-BD0D31F22DB9</gtr:id><gtr:title>SCP2 mutations and neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56c9e480dc6a25.53341292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D95A03EC-2B39-4034-8A30-C4B16FD92F37</gtr:id><gtr:title>Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4fe90f775f7ad2b26d983c719e78eb"><gtr:id>bd4fe90f775f7ad2b26d983c719e78eb</gtr:id><gtr:otherNames>Davidson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12524_24_22302274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8A72796-026C-467D-9D42-5D19154E745D</gtr:id><gtr:title>Erratum to: The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89b31b53bd8d22167e3e61b6f878f7e4"><gtr:id>89b31b53bd8d22167e3e61b6f878f7e4</gtr:id><gtr:otherNames>Guthrie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56c9e482635f57.47899012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C937A08-0320-445E-BE11-577D2DEB73EB</gtr:id><gtr:title>Store-Operated CaEntry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dee32292c70994b6b9c055d18407310a"><gtr:id>dee32292c70994b6b9c055d18407310a</gtr:id><gtr:otherNames>Maus M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>58a19f820833a4.65006538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>661E87A3-1236-42A5-96F4-1632590F718A</gtr:id><gtr:title>Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/666c1bca35822325694519446dc7f903"><gtr:id>666c1bca35822325694519446dc7f903</gtr:id><gtr:otherNames>Weckhuysen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12524_24_24107868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CB31F8F-EDD1-4251-9229-32B45CB4DBC2</gtr:id><gtr:title>Retrospective assessment of the most common mitochondrial DNA mutations in a large Hungarian cohort of suspect mitochondrial cases.</gtr:title><gtr:parentPublicationTitle>Mitochondrial DNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f999533405112c226eeece3936a39ac5"><gtr:id>f999533405112c226eeece3936a39ac5</gtr:id><gtr:otherNames>Remenyi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1940-1736</gtr:issn><gtr:outcomeId>5458f56c104e93.08493799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4299CB7-BD5B-4B06-8AE4-005039450B4B</gtr:id><gtr:title>The Effect of Neurological Genomics and Personalized Mitochondrial Medicine.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58a19f81279581.50479582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9E5502A-086A-4B08-B9B6-A00803CE60B0</gtr:id><gtr:title>Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b09cec3df0253fb5c98e8674910a85a"><gtr:id>3b09cec3df0253fb5c98e8674910a85a</gtr:id><gtr:otherNames>Herrmann DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5458f2b5c4fcf3.28238611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD72DF57-B20D-4F2B-BD9E-F31C15880A80</gtr:id><gtr:title>An unusual gait following the discovery of a new disease.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>dJM53ThWuta</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9210252C-FD4F-4521-B039-BC5F3DD5A43F</gtr:id><gtr:title>Exome sequencing in undiagnosed inherited and sporadic ataxias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9859857881c5f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3DF3A0A-EFAF-4CF1-B923-9893C0C65F01</gtr:id><gtr:title>Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3f67872dd1dc9f834d9785e1b547290"><gtr:id>f3f67872dd1dc9f834d9785e1b547290</gtr:id><gtr:otherNames>Olsen RKJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>585d695c9dc109.40461695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7544170-49EE-4CE3-8412-D38B193A77DA</gtr:id><gtr:title>Homozygous deletion in MICU1 presenting with fatigue and lethargy in childhood.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca96d1966f0778644c32e881ef5a5f3d"><gtr:id>ca96d1966f0778644c32e881ef5a5f3d</gtr:id><gtr:otherNames>Lewis-Smith D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58a19f80055475.16931035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70911857-FE0B-427F-AD6E-511F595EB0D5</gtr:id><gtr:title>PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c692328de2b7dacbeb9ee898d4a29a2"><gtr:id>0c692328de2b7dacbeb9ee898d4a29a2</gtr:id><gtr:otherNames>Juneja M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5a9f1a027a3e55.52049189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1D690E2-550B-42D2-ACBD-6A5F2D68B3F0</gtr:id><gtr:title>Phenotypic convergence of Menkes and Wilson disease.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40a020e11c4ea5657e5f2e6f3485cfd0"><gtr:id>40a020e11c4ea5657e5f2e6f3485cfd0</gtr:id><gtr:otherNames>Bansagi B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58a19f8176e473.01739607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4A0B752-17BD-4E10-85A9-1CEE13084D12</gtr:id><gtr:title>An under-recognised cause of spastic paraparesis in middle-aged women.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c967a786847e7e5db1d802a30f49fbb9"><gtr:id>c967a786847e7e5db1d802a30f49fbb9</gtr:id><gtr:otherNames>Bargiela D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>5458f650440110.90741232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3828EBD-9AB8-4355-9714-2176E70AE1FE</gtr:id><gtr:title>Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d3a74312ac86d45efc47ac78a3c98c"><gtr:id>35d3a74312ac86d45efc47ac78a3c98c</gtr:id><gtr:otherNames>Haack TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58a19f80533b00.43190107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AB1BCDB-BF80-427C-9996-59846D34E290</gtr:id><gtr:title>ANO10 mutations cause ataxia and coenzyme Q10 deficiency.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bdf1a60ea99c281a61ce794e1157fe6"><gtr:id>5bdf1a60ea99c281a61ce794e1157fe6</gtr:id><gtr:otherNames>Balreira A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>doi_55f94594529448af</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>899B1663-DCE7-45C2-81F1-5C4C7D4F54C5</gtr:id><gtr:title>Clinical heterogeneity of primary familial brain calcification due to a novel mutation in PDGFB.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5675e1ae2f279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5864BC13-5213-4313-99FA-E1918285DFDE</gtr:id><gtr:title>Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular probes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b46a059d17a7e6e21fea65a261eb2d3"><gtr:id>5b46a059d17a7e6e21fea65a261eb2d3</gtr:id><gtr:otherNames>K?hler C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0890-8508</gtr:issn><gtr:outcomeId>56c9e4801d1c82.52331382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D589CCA-5901-49CB-AC5C-F3051F9C86F0</gtr:id><gtr:title>Prominent sensorimotor neuropathy due to SACS mutations revealed by whole-exome sequencing.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm_12524_24_22751902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16D1BB60-199E-4698-9D5A-7CFBEF6FCB20</gtr:id><gtr:title>Brain iron takes off: a new propeller protein links neurodegeneration with autophagy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12524_24_23674487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B1E23EE-1287-43E4-AFE7-FCC082FE6080</gtr:id><gtr:title>Altered RNA metabolism due to a homozygous RBM7 mutation in a patient with spinal motor neuropathy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97e893847bdd75f81e7aed11562f0996"><gtr:id>97e893847bdd75f81e7aed11562f0996</gtr:id><gtr:otherNames>Giunta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58a19f7fab7c16.89317936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE8C48C2-0BFD-4C14-BAE9-D03071012151</gtr:id><gtr:title>Prevalence of neurogenetic disorders in the North of England.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c967a786847e7e5db1d802a30f49fbb9"><gtr:id>c967a786847e7e5db1d802a30f49fbb9</gtr:id><gtr:otherNames>Bargiela D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56c9e48046b119.16388301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>295FC127-F8A0-4A01-A0B0-A53A47A9FE30</gtr:id><gtr:title>Clinical and functional characterisation of the combined respiratory chain defect in two sisters due to autosomal recessive mutations in MTFMT.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d1ffbd27c5115fb37fa981f335d80e"><gtr:id>88d1ffbd27c5115fb37fa981f335d80e</gtr:id><gtr:otherNames>Neeve VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>pm_12524_24_23499752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE75F7B3-9025-442A-A7FA-71E79996B7FA</gtr:id><gtr:title>In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21120c5a83ffe6b0704e78412e17c3e8"><gtr:id>21120c5a83ffe6b0704e78412e17c3e8</gtr:id><gtr:otherNames>Bulst S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>pm_12524_24_22608879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A8DECE4-45DC-43D2-A266-959DBB81A242</gtr:id><gtr:title>The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/426814ae3d00276b2973974ab4eff106"><gtr:id>426814ae3d00276b2973974ab4eff106</gtr:id><gtr:otherNames>Reilich P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>X1Ghva5bJor</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F87A3D69-A439-4CAE-82F2-21F95A277364</gtr:id><gtr:title>AMACR mutations cause late-onset autosomal recessive cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa58864b5a96cc3b19b28e2632005722"><gtr:id>fa58864b5a96cc3b19b28e2632005722</gtr:id><gtr:otherNames>Dick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>PgvpEHpuqCj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C957DEFD-AAEF-40FE-B09E-D1F09F443E2E</gtr:id><gtr:title>Titin mutation segregates with hereditary myopathy with early respiratory failure.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12524_24_22577215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B883946-1498-4897-933C-E2C24626EB64</gtr:id><gtr:title>An Unusual Retinal Phenotype Associated With a Mutation in Sterol Carrier Protein SCP2.</gtr:title><gtr:parentPublicationTitle>JAMA ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6140c75e317bc4b0660733732ad4155c"><gtr:id>6140c75e317bc4b0660733732ad4155c</gtr:id><gtr:otherNames>Morarji J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6165</gtr:issn><gtr:outcomeId>58a19f81d75a57.92849539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ECB2B1B-062E-4C58-AA71-ACF79C295345</gtr:id><gtr:title>Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6ab13390a03bb47cc0c9895a3246407"><gtr:id>d6ab13390a03bb47cc0c9895a3246407</gtr:id><gtr:otherNames>Talim B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12524_24_23008233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CC10E7C-72EE-4799-A7F0-091D9FDEAB31</gtr:id><gtr:title>Progressive brain iron accumulation in neuroferritinopathy measured by the thalamic T2* relaxation rate.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb527c8f47b11cfd2bb90849f52723e8"><gtr:id>fb527c8f47b11cfd2bb90849f52723e8</gtr:id><gtr:otherNames>McNeill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_12524_24_22499840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46CD25FA-BC1F-4AE1-8A5B-0380FF10AEC5</gtr:id><gtr:title>What is influencing the phenotype of the common homozygous polymerase-? mutation p.Ala467Thr?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d1ffbd27c5115fb37fa981f335d80e"><gtr:id>88d1ffbd27c5115fb37fa981f335d80e</gtr:id><gtr:otherNames>Neeve VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12524_24_23250882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83BF7DE1-8D09-4B24-A32D-F76A911444D3</gtr:id><gtr:title>NDUFS8-related Complex I Deficiency Extends Phenotype from &amp;quot;PEO Plus&amp;quot; to Leigh Syndrome.</gtr:title><gtr:parentPublicationTitle>JIMD reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af3b9089a043ed6fa458b831e348da7a"><gtr:id>af3b9089a043ed6fa458b831e348da7a</gtr:id><gtr:otherNames>Marina AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2192-8304</gtr:issn><gtr:outcomeId>pm_12524_24_23430795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B9E4379-E6F4-4CFA-8A1A-C97801BB0BDE</gtr:id><gtr:title>ATP synthase deficiency due to TMEM70 mutation leads to ultrastructural mitochondrial degeneration and is amenable to treatment.</gtr:title><gtr:parentPublicationTitle>BioMed research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0fe295aa0422e6a50e86dc3492e525c"><gtr:id>a0fe295aa0422e6a50e86dc3492e525c</gtr:id><gtr:otherNames>Braczynski AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56c9e481a88c55.01003581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA72920D-BB1F-4739-BFAB-06ADC0EFCEE9</gtr:id><gtr:title>Recurrent stroke-like episodes in X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f56c2da55d8d224cf3f95ba92c0ca437"><gtr:id>f56c2da55d8d224cf3f95ba92c0ca437</gtr:id><gtr:otherNames>Basu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>irwp55D6Qyy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>317F43AF-E6D2-4361-AC49-5293FE6C87E1</gtr:id><gtr:title>Deficiency of the mitochondrial phosphate carrier presenting as myopathy and cardiomyopathy in a family with three affected children.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71fa0a7ba72192008693e52351893b1d"><gtr:id>71fa0a7ba72192008693e52351893b1d</gtr:id><gtr:otherNames>Mayr JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>Y1NEhAzjT7R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5CF4E42-9B3E-4B5C-9F67-CF9CDEF28EE7</gtr:id><gtr:title>Epilepsy in adults with mitochondrial disease: A cohort study.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e87940e6460d8a108148a5e207bd528"><gtr:id>0e87940e6460d8a108148a5e207bd528</gtr:id><gtr:otherNames>Whittaker RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56c9e480a85807.23385323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0A8DCF7-B7E1-42D1-8EAD-F2162BDD67F4</gtr:id><gtr:title>Whole exome sequencing and the clinician: we need clinical skills and functional validation in variant filtering.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c19598be474cb49282eca984c7b19308"><gtr:id>c19598be474cb49282eca984c7b19308</gtr:id><gtr:otherNames>Daud D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5675e4261f5c0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CF372E9-B8CD-49CF-B0AC-864B60CEF8E7</gtr:id><gtr:title>Mitochondrial pathology in progressive cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Cerebellum &amp; ataxias</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c967a786847e7e5db1d802a30f49fbb9"><gtr:id>c967a786847e7e5db1d802a30f49fbb9</gtr:id><gtr:otherNames>Bargiela D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2053-8871</gtr:issn><gtr:outcomeId>56c9e481db0f77.20482439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15207B50-22F9-4E62-8198-691595BBED15</gtr:id><gtr:title>Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12524_24_23107649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>504367FD-689D-4380-87D6-7058C59C6947</gtr:id><gtr:title>Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bc1e6261a073e8c97bb04481b8202a"><gtr:id>a3bc1e6261a073e8c97bb04481b8202a</gtr:id><gtr:otherNames>Taylor RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>doi_55f945945281c1e1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>763E737E-9A18-45D8-A2F7-9698692E4EA6</gtr:id><gtr:title>Amyloid-? in mitochondrial disease: mutation in a human metallopeptidase links amyloidotic neurodegeneration with mitochondrial processing.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>56c9e482396443.32959025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>972C4166-C8C8-498E-96FD-78FC381FE279</gtr:id><gtr:title>New treatments for mitochondrial disease-no time to drop our standards.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_12524_24_23817350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFF5EA4C-97D8-4CE6-A2CE-7BD61117D0DA</gtr:id><gtr:title>Novel homozygous RARS2 mutation in two siblings without pontocerebellar hypoplasia - further expansion of the phenotypic spectrum.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5fb40a96f9d7c858444a8f0911ed61b"><gtr:id>b5fb40a96f9d7c858444a8f0911ed61b</gtr:id><gtr:otherNames>L?hl S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>58a19f809f5c34.55199755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>534F5107-3294-4401-AEBE-0BB0201AF665</gtr:id><gtr:title>Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay in the Time of Next-Generation Sequencing-Reply</gtr:title><gtr:parentPublicationTitle>Archives of Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12524_24_23229047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8615C776-7ABC-4336-B506-2976F34B3864</gtr:id><gtr:title>EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5458f380dd7379.52709893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB4D5059-3539-4396-9383-F44CB72E2E1A</gtr:id><gtr:title>Reversible infantile mitochondrial diseases.</gtr:title><gtr:parentPublicationTitle>Journal of inherited metabolic disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0141-8955</gtr:issn><gtr:outcomeId>5675dcec7ba96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ECD8778-66FE-4C27-A2DE-95ACB9659855</gtr:id><gtr:title>Genetic variations within the OPA1 gene are not associated with neuromyelitis optica.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis (Houndmills, Basingstoke, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1352-4585</gtr:issn><gtr:outcomeId>n2W5KmKobTZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D90D00D4-1104-49EA-BA9E-F645E409A5D7</gtr:id><gtr:title>Mitochondria: impaired mitochondrial translation in human disease.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5458f58dc3b3c4.15777322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D8B62AC-B04C-4E28-B723-DFB57A8797D0</gtr:id><gtr:title>Altered 2-thiouridylation impairs mitochondrial translation in reversible infantile respiratory chain deficiency.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12524_24_23814040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4508B2A4-1ACC-4A57-ABFE-8A3412031404</gtr:id><gtr:title>Phenotypic variability of TRPV4 related neuropathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe8fc4c7a21a2eb5369f6c0eb70d891a"><gtr:id>fe8fc4c7a21a2eb5369f6c0eb70d891a</gtr:id><gtr:otherNames>Evangelista T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>5675e2f66beba</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>277B715F-A218-4711-AB64-0F2F843FCDB3</gtr:id><gtr:title>Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>R2iWFKwxbXN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CB9AED-AAD5-4160-A7DD-A9E4DAB5568E</gtr:id><gtr:title>Cysteine Supplementation May be Beneficial in a Subgroup of Mitochondrial Translation Deficiencies.</gtr:title><gtr:parentPublicationTitle>Journal of neuromuscular diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bdc173cc903af2b23be1f55ff257851"><gtr:id>1bdc173cc903af2b23be1f55ff257851</gtr:id><gtr:otherNames>Bartsakoulia M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58a19f81523fe3.25358728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05A9FBBF-D3E0-44E4-9329-5BD70AB9AFB7</gtr:id><gtr:title>Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99fcf07122666dd23e6cca7816fda75"><gtr:id>d99fcf07122666dd23e6cca7816fda75</gtr:id><gtr:otherNames>Wilson IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56c9e482123f02.25178413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDCE0A3E-17DB-4FDC-8E46-0967171E9C57</gtr:id><gtr:title>The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89b31b53bd8d22167e3e61b6f878f7e4"><gtr:id>89b31b53bd8d22167e3e61b6f878f7e4</gtr:id><gtr:otherNames>Guthrie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12524_24_23238845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3059AE1-290E-453E-AE82-644837FCC178</gtr:id><gtr:title>Frequency of rare recessive mutations in unexplained late onset cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5675e483b251e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF84B7B6-799F-46EB-B60A-6AA116629673</gtr:id><gtr:title>Two recurrent mutations are associated with GNE myopathy in the North of Britain.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92cf2dd7e98f0d1ff4c60ca219551d89"><gtr:id>92cf2dd7e98f0d1ff4c60ca219551d89</gtr:id><gtr:otherNames>Chaouch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5458f4182929b8.08824510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4FCB1E6-681D-424E-B548-AEC162DED5A9</gtr:id><gtr:title>Emerging therapies for mitochondrial disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856a4d55b01d92abca12d16202621560"><gtr:id>856a4d55b01d92abca12d16202621560</gtr:id><gtr:otherNames>Nightingale H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58a19f7f787a33.55457572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>332D4AEA-1EA0-4555-8AE2-77C56AC099C5</gtr:id><gtr:title>Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12524_24_22577227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1806A7FB-FE1B-440A-9DDF-D7CDF794FCAA</gtr:id><gtr:title>Mitochondrial dysfunction in liver failure requiring transplantation.</gtr:title><gtr:parentPublicationTitle>Journal of inherited metabolic disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa9b360d10099bbc9e1acdd7798f4d8f"><gtr:id>fa9b360d10099bbc9e1acdd7798f4d8f</gtr:id><gtr:otherNames>Lane M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0141-8955</gtr:issn><gtr:outcomeId>585d32c2edc871.87812317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>902D8676-E798-42DB-9E97-22CF3A42C926</gtr:id><gtr:title>Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/239fde08f90ad218305bbe68e6bbfffd"><gtr:id>239fde08f90ad218305bbe68e6bbfffd</gtr:id><gtr:otherNames>Shields MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fd63035f475.84654046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B7D9B8A-D97A-4EDD-B539-822DE3D534B5</gtr:id><gtr:title>RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f950fd99d3923d0e32eb2c63f89184e9"><gtr:id>f950fd99d3923d0e32eb2c63f89184e9</gtr:id><gtr:otherNames>Fratter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>NmYrwjxfykQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA2D6A8B-AA36-4DB0-8C62-ED46207C9466</gtr:id><gtr:title>Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d3a74312ac86d45efc47ac78a3c98c"><gtr:id>35d3a74312ac86d45efc47ac78a3c98c</gtr:id><gtr:otherNames>Haack TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_12524_24_22200994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F857D85E-C6DE-4238-A0C8-4F128D6F542D</gtr:id><gtr:title>Fibroblast growth factor 21, a biomarker for mitochondrial muscle disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/377e17ef3a2cc450fe710042793f483a"><gtr:id>377e17ef3a2cc450fe710042793f483a</gtr:id><gtr:otherNames>Gavrilova R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5458f670a56cb6.54490086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4B59440-85C1-4218-8AB4-12838262290A</gtr:id><gtr:title>AP4 deficiency: A novel form of neurodegeneration with brain iron accumulation?</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fee03308b2db8abf7ae09f70c5e30906"><gtr:id>fee03308b2db8abf7ae09f70c5e30906</gtr:id><gtr:otherNames>Roubertie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5a9f1a020fe2f4.20572622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FE0E9C0-6DEF-4C0D-B484-4EC30B8803EB</gtr:id><gtr:title>De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92f452f90128c037a36d03c05cdb5804"><gtr:id>92f452f90128c037a36d03c05cdb5804</gtr:id><gtr:otherNames>Sleven H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58a19f81a4aa60.16590709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4E48EF9-A0E9-4AA2-969E-2F85337A045B</gtr:id><gtr:title>Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10).</gtr:title><gtr:parentPublicationTitle>Journal of inherited metabolic disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0141-8955</gtr:issn><gtr:outcomeId>pm_12524_24_22231380</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000848</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>